How reimbursement databases can be used to support drug utilisation studies: Example using the main French national health insurance system database

European Journal of Clinical Pharmacology

Volumn 66, Issue 7, 2010, Pages 743-748

  Latry, Philippe ^a   Molimard, Mathieu ^b,c,d   Bégaud, Bernard ^b,c,d   Martin Latry, Karin ^b,c,d  

^a Cnam TS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM U657   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Databases; France; Health insurance; Pharmacoepidemiology; Reimbursement

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIARRHEAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; CORTICOSTEROID DERIVATIVE; LAXATIVE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; SEX HORMONE; TOPICAL AGENT; VACCINE; VITAMIN; DRUG;

ARTICLE; DATA BASE; DRUG COST; DRUG MARKETING; DRUG UTILIZATION; FRANCE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; NATIONAL HEALTH INSURANCE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; RELIABILITY; COMPARATIVE STUDY; ECONOMICS; FACTUAL DATABASE; HUMAN; PHARMACOEPIDEMIOLOGY; PROCEDURES; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

DATABASES, FACTUAL; DRUG UTILIZATION; FRANCE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; NATIONAL HEALTH PROGRAMS; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY;

EID: 77955574300     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0819-0     Document Type: Article

References (24)

1. Strom B (2006) Pharmacoepidemiology. Wiley, Chichester
2. Hennessy S, Carson J, Ray W, Strom B (2006) Medicaid databases. In: Strom B (ed) Pharmacoepidemiology, 4th ed. Wiley, Chichester, pp 281-294
3. Chan K, Davis R, Gunter M, Gurwitz J, Herrinton L, Nelson W, Raebel M, Roblin D, Smith D, Platt R (2006) The HMO research network. In: Strom B (ed) Pharmacoepidemiology, 4th ed. Wiley, Chichester, pp 261-270
4. Securite Sociale, l'Assurance Maladie (2008) Medic-AM 2002-2007. http://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/ donnees-statistiques/medic-am-generic-am-biolam-lpp-am/medicam-2002-2007.php. Accessed 12 February 2009
5. Direction de l'Evaluation de la Publicité et des Produits Cosmétiques (2008) Analysis of drugs' sales for community pharmacies and hospitals in France (in French), 8th ed. Afssaps, Saint Denis
6. Article L5121-17 du code de la santé publique. modifié par LOI no 2008-1425 du 27 décembre 2008 - art. 177 (V). http://www. legifrance.gouv.fr. Accessed 9 February 2010
7. DRESS (2001) La consommation de médicament non prescrit, no.105. http://www.sante.gouv.fr/drees/etude-resultat/er-pdf/er105.pdf. Accessed 12 June 2009
8. CNHIM (2010) Theriaque. http://www.theriaque.org/ Accessed 9 February 2010
9. Lacroix I, Hurault C, Sarramon MF, Guitard C, Berrebi A, Grau M, Albouy-Cossard C, Bourrel R, Elefant E, Montastruc JL, Damase-Michel C (2009) Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 65(8):839-846. doi:10.1007/s00228-009-0647-2
10. Szarewski A, Mansour D (1999) The 'pill scare': the responses of authorities, doctors and patients using oral contraceptives. Hum Reprod Update 5:627-632
11. Editorial, Wall Street Journal, May 31, 2005
12. Mikaeloff Y, Kezouh A, Suissa S (2008) Nonsteroidal antiinflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol 65(2):203-209
13. Patterson MK, Castellsague J, Walker AM (2008) Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib. Pharmacoepidemiol Drug Saf 17(10):982-988
14. Wei L, Fahey T, MacDonald TM (2008) Adherence to statin or aspirin or both in patients with established cardiovascular disease:exploring healthy behaviour vs. drug effects and 10-year followup of outcome. Br J Clin Pharmacol 66(1):110-116
15. Fosbol EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, Folke F, Sorensen R, Rasmussen JN, Kober L, Madsen M, Torp-Pedersen C (2008) The pattern of use of nonsteroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf 17(8):822-833
16. Walley T, Folino-Gallo P, Schwabe U, Van Ganse E, Stephens P (2004) Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe. Eur J Clin Pharmacol 60(7):503-511. doi:10.1007/s00228-004-0801-9 (Pubitemid 39350163)
17. Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W (2005) Antipsychotic exposure and type 2 diabetes among patients withschizophrenia: a matched case-control study of California Medicaid claims. Pharmacoepidemiol Drug Saf 14(6):417-425
18. Ward A, Ishak K, Proskorovsky I, Caro J (2006) Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study. Clin Ther 28(11):1912-1921
19. Gagne JJ, Maio V, Berghella V, Louis DZ, Gonnella JS (2008) Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol 64 (11):1125-1132
20. Perreault S, Dragomir A, Blais L, Berard A, Lalonde L, White M, Pilon D (2009) Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol 65(10):1013-1024. doi:10.1007/s00228-009-0673-0
21. Lachaine J, Rinfret S, Merikle EP, Tarride JE (2006) Persistence and adherence to cholesterol lowering agents: evidence from Regie de l'Assurance Maladie du Quebec data. Am Heart J 152 (1):164-169
22. Catalan VS, LeLorier J (2000) Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 3 (6):417-426
23. Vinker S, Shani M, Baevsky T, Elhayany A (2008) Adherence with statins over 8 years in a usual care setting. Am J Manag Care 14(6):388-392
24. Martin-Latry K, Begaud B (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19(3):256-265. doi:10.1002/pds.1912